Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese HSK 1 – For Medical Students & Physicians A complete 20-lesson, 300-page Chinese HSK 1 course with a companion app in 21 languages — free forever. Arabic, Bengali, Dutch, English, Farsi, French, German, Hindi, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Tagalog, Thai, Turkish, Ukrainian, Urdu, Vietnamese. By Bernd Sebastian Kamps and Andrea Melis

Drug Resistance

Free Subscription Articles published in AIDS Retrieve available abstracts of 24 articles: HTML format

Single Articles

April 2026
1. TAO K, Tzou PL, Sahoo MK, Hare CB, et al
   HIV-1 subtype diversity trends in a Northern California cohort.
   AIDS. 2026;40:530-532.
   PubMed     Abstract available
   
   
   January 2026
2. CORDOVA E, Rendon JH, Calderon GA, Seleme S, et al
   Efficacy of dolutegravir plus lamivudine in treatment-naive people with HIV with baseline transmitted drug-resistance mutations.
   AIDS. 2026 Jan 15. doi: 10.1097/QAD.0000000000004444.
   PubMed     Abstract available
   
   
   
3. KOVALENKO G, Liulchuk MG, Filippovych M, Smyrnov P, et al
   VANTAGE: van-based real-time HIV sequencing for transmission mapping and drug resistance profiling in war-affected Ukraine.
   AIDS. 2026;40:123-126.
   PubMed     Abstract available
   
   
   December 2025
4. MARCELIN AG, Soulie C, Wirden M, Gruber J, et al
   Antiretroviral resistance in at least second-line HIV-1 treatment virologic failure with common InSTI-based regimens.
   AIDS. 2025 Dec 30. doi: 10.1097/QAD.0000000000004438.
   PubMed     Abstract available
   
   
   
5. VELOSO M, Ribeiro M, Cabanas J, Goncalves F, et al
   Emerging patterns in HIV integrase resistance.
   AIDS. 2025;39:2324-2327.
   PubMed     Abstract available
   
   
   
6. DE ARMAS LR, Tuyishime M, Justement JS, Jha S, et al
   Resistance to broadly neutralizing antibodies in perinatally infected infants from a Clade C HIV cohort in Mozambique.
   AIDS. 2025;39:2321-2324.
   PubMed     Abstract available
   
   
   November 2025
7. BISHOP MD, Xu L, Boyce CL, Drain PK, et al
   HIV-1 3? polypurine tract mutations and integrase inhibitor resistance.
   AIDS. 2025;39:1996-2013.
   PubMed     Abstract available
   
   
   September 2025
8. NAIK V, Nekkalapudi A, Boopathy AV, Falkard B, et al
   Emergence of in vitro resistance to lenacapavir is similar across HIV-1 subtypes.
   AIDS. 2025 Sep 18. doi: 10.1097/QAD.0000000000004334.
   PubMed     Abstract available
   
   
   
9. SOULIE C, Balde A, Fofana D, Charpentier C, et al
   No evidence of an effect of the M184I/V on the doravirine/lamivudine/tenofovir switch efficacy in people living with HIV.
   AIDS. 2025 Sep 8. doi: 10.1097/QAD.0000000000004339.
   PubMed     Abstract available
   
   
   August 2025
10. CALCAGNO A, Carola L, Barbara R, Marco M, et al
    Full reservoirs and poor adherence: two cases of symptomatic HIV cerebrospinal fluid escape with tenofovir alafenamide/emtricitabine/bictegravir.
    AIDS. 2025 Aug 8. doi: 10.1097/QAD.0000000000004320.
    PubMed     Abstract available
    
    
    June 2025
11. MERAD Y, Mariaggi AA, Karmochkine M, Slama L, et al
    Virological success despite archived INSTI drug resistance mutations on INSTI-based antiretroviral regimens.
    AIDS. 2025 Jun 5. doi: 10.1097/QAD.0000000000004251.
    PubMed     Abstract available
    
    
    May 2025
12. CLEMENTE T, Bellomo M, Raccagni AR, Lolatto R, et al
    Sexually transmitted infections in men who have sex with men with tenofovir/emtricitabine- or cabotegravir-resistant HIV.
    AIDS. 2025 May 3. doi: 10.1097/QAD.0000000000004225.
    PubMed     Abstract available
    
    
    April 2025
13. ZHANG R, Chung SL, Lee SS, Wong NS, et al
    Prevalence and resistance patterns of Mycoplasma genitalium infection in people living with HIV: a systematic review and meta-analysis.
    AIDS. 2025 Apr 22. doi: 10.1097/QAD.0000000000004219.
    PubMed     Abstract available
    
    
    
14. GLENN JS, Bennett A, Mackie N, Lyall H, et al
    The cumulative prevalence of HIV-1 drug resistance in perinatal HIV.
    AIDS. 2025 Apr 4. doi: 10.1097/QAD.0000000000004202.
    PubMed     Abstract available
    
    
    March 2025
15. MUCCINI C, Spagnuolo V, Zazzi M, Castagna A, et al
    People with four-class drug-resistant HIV-1 may have low levels of intact DNA.
    AIDS. 2025;39:475-476.
    PubMed     Abstract available
    
    
    
16. INZAULE S, Jordan MR, Fokam J, Hamers RL, et al
    Non-canonical HIV drug resistance mutations: need to close existing gaps.
    AIDS. 2025 Mar 6. doi: 10.1097/QAD.0000000000004170.
    PubMed     Abstract available
    
    
    February 2025
17. WAGNER T, Levy I, Wieder-Finesod A, Wax M, et al
    Drug resistance testing at regimen failure in individuals diagnosed with HIV-1 between 2010 and 2018 in Israel.
    AIDS. 2025 Feb 3. doi: 10.1097/QAD.0000000000004138.
    PubMed     Abstract available
    
    
    October 2024
18. ENI-OLUTU A, Mackie NE, Glenn J, Bailey A, et al
    Emerging integrase resistance in an international perinatal virtual clinic.
    AIDS. 2024 Oct 28. doi: 10.1097/QAD.0000000000004048.
    PubMed     Abstract available
    
    
    
19. CLEMENTE T, Pontillo D, Malagnino V, Calza L, et al
    Cancer in people with multidrug-resistant HIV.
    AIDS. 2024;38:1801-1806.
    PubMed     Abstract available
    
    
    September 2024
20. ZANIEWSKI E, Skrivankova VW, Brazier E, Avihingsanon A, et al
    Transition to dolutegravir-based ART in 35 low- and middle-income countries: a global survey of HIV care clinics.
    AIDS. 2024 Sep 5. doi: 10.1097/QAD.0000000000004007.
    PubMed     Abstract available
    
    
    
21. BURGER D, Wttewaal E, Oosterhof P, Stalenhoef J, et al
    Concomitant use of anabolic androgen steroids and cabotegravir/rilpivirine leading to virological failure and development of two-class resistance.
    AIDS. 2024;38:1728-1729.
    PubMed    
    
    
    July 2024
22. KARABAY O
    Concerns and clarifications regarding the article 'Virological, weight, and drug resistance outcomes among patients initiating a dolutegravir-based first line ART regimen in Zimbabwe'.
    AIDS. 2024;38:1273.
    PubMed    
    
    
    March 2024
23. PAPAIOANNU BORJESSON R, Galli L, Lolatto R, Menzaghi B, et al
    Lower aids-related hospitalizations in women living with HIV multidrug resistance.
    AIDS. 2024;38:435-438.
    PubMed    
    
    
    February 2024
24. GONCALVES P, Barreto J, Santos M, Leal S, et al
    HIV-1 drug resistance and genetic diversity in people with HIV-1 in Cape Verde, 2019-2021.
    AIDS. 2024 Feb 13. doi: 10.1097/QAD.0000000000003866.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum